Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance

Wael A. AlJaroudi; Fadi G. Hage

doi:10.1007/s12350-017-1120-8

Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance

Wael A. AlJaroudi, Fadi G. Hage

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Several original articles and editorials have been published in the Journal of Nuclear Cardiology in 2017. It has become a tradition at the beginning of each year to summarize some of these key articles in 2 sister reviews. In this first part one, we will discuss some of the progress made in the field of heart failure (cardio-oncology, myocardial blood flow, viability, dyssynchrony, and risk stratification), inflammation, molecular and hybrid imaging using advancement in positron emission tomography, computed tomography, and magnetic resonance imaging.

Original language	English (US)
Pages (from-to)	320-330
Number of pages	11
Journal	Journal of Nuclear Cardiology
Volume	25
Issue number	1
DOIs	https://doi.org/10.1007/s12350-017-1120-8
State	Published - Feb 1 2018
Externally published	Yes

Keywords

Positron emission tomography
cardio-oncology
computed tomography
dyssynchrony
heart failure
magnetic resonance imaging

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s12350-017-1120-8

Cite this

@article{55e6b239c66c41fa9dcaf586c973b3ed,

title = "Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance",

abstract = "Several original articles and editorials have been published in the Journal of Nuclear Cardiology in 2017. It has become a tradition at the beginning of each year to summarize some of these key articles in 2 sister reviews. In this first part one, we will discuss some of the progress made in the field of heart failure (cardio-oncology, myocardial blood flow, viability, dyssynchrony, and risk stratification), inflammation, molecular and hybrid imaging using advancement in positron emission tomography, computed tomography, and magnetic resonance imaging.",

keywords = "Positron emission tomography, cardio-oncology, computed tomography, dyssynchrony, heart failure, magnetic resonance imaging",

author = "AlJaroudi, {Wael A.} and Hage, {Fadi G.}",

note = "Funding Information: Dr. Hage reports research grant support from Astellas Pharma. Publisher Copyright: {\textcopyright} 2017, American Society of Nuclear Cardiology.",

year = "2018",

month = feb,

day = "1",

doi = "10.1007/s12350-017-1120-8",

language = "English (US)",

volume = "25",

pages = "320--330",

journal = "Journal of Nuclear Cardiology",

issn = "1071-3581",

publisher = "Springer New York",

number = "1",

}

TY - JOUR

T1 - Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2

T2 - Positron emission tomography, computed tomography, and magnetic resonance

AU - AlJaroudi, Wael A.

AU - Hage, Fadi G.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Several original articles and editorials have been published in the Journal of Nuclear Cardiology in 2017. It has become a tradition at the beginning of each year to summarize some of these key articles in 2 sister reviews. In this first part one, we will discuss some of the progress made in the field of heart failure (cardio-oncology, myocardial blood flow, viability, dyssynchrony, and risk stratification), inflammation, molecular and hybrid imaging using advancement in positron emission tomography, computed tomography, and magnetic resonance imaging.

AB - Several original articles and editorials have been published in the Journal of Nuclear Cardiology in 2017. It has become a tradition at the beginning of each year to summarize some of these key articles in 2 sister reviews. In this first part one, we will discuss some of the progress made in the field of heart failure (cardio-oncology, myocardial blood flow, viability, dyssynchrony, and risk stratification), inflammation, molecular and hybrid imaging using advancement in positron emission tomography, computed tomography, and magnetic resonance imaging.

KW - Positron emission tomography

KW - cardio-oncology

KW - computed tomography

KW - dyssynchrony

KW - heart failure

KW - magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=85033401209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033401209&partnerID=8YFLogxK

U2 - 10.1007/s12350-017-1120-8

DO - 10.1007/s12350-017-1120-8

M3 - Review article

C2 - 29119374

AN - SCOPUS:85033401209

SN - 1071-3581

VL - 25

SP - 320

EP - 330

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

IS - 1

ER -

Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this